Ethical, social, and cultural considerations for site selection for research with genetically modified mosquitoes

American Journal of Tropical Medicine and Hygiene

Volumn 79, Issue 3, 2008, Pages 312-318

  Lavery, James V ^a   Harrington, Laura C ^b   Scott, Thomas W ^c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b Department of Obstetrics Gynecology   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CULTURAL FACTOR; DNA MODIFICATION; INFECTION CONTROL; MEDICAL ETHICS; MEDICAL RESEARCH; MOSQUITO; REVIEW; SOCIAL ASPECT; TRANSGENIC ORGANISM;

DENGUE VIRUS GROUP;

EID: 51949088717     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2008.79.312     Document Type: Review

References (23)

1. Collins FA, James AA, 1996. Genetic modifications of mosquitoes. Sci Med (Phila) 3: 52-61.
2. Aultman KS, Walker ED, Gifford F, Severson DW, Beard CB, Scott TW, 2000. Research ethics. Managing risks of arthropod vector research. Science 288: 2321-2322.
3. Pew Initiative on Food and Biotechnology, 2004. Bugs in the System? Issues in the Science and Regulation of Genetically Modified Insects. Available at: http://www.pewtrusts.org/our_work_report_detail.aspx?id=17984. Accessed July 9, 2008.
4. Knols BGJ, Bossin H, 2004. Identification and characterization of field sites for genetic control of disease vectors. Knols BGJ, Louis C, eds. Bridging Laboratory and Field Research for Genetic Control of Disease Vectors. Wageningen, The Netherlands: Springer/Frontis, 203-209.
5. Touré YT, Oduola AMJ, Sommerfeld J, Morel CM, 2004. Biosafety and risk assessment in the use of genetically modified mosquitoes for disease control. Knols BGJ, Louis C, eds. Bridging Laboratory and Field Research for Genetic Control of Disease Vectors. Wageningen, The Netherlands: Springer/Frontis, 217-222.
6. Macer D, 2003. Ethical, legal and social issues of genetically modified disease vectors in public health. Social, economic and behavioural research. Special Topics No. 1. Geneva: TDR/WHO. Available at: http://www.who.int/tdr/ publications/publications/pdf/seb_topicl.pdf. Accessed July 9, 2008.
7. Edeger TT, 1999. North-south research partnerships: the ethics of carrying out research in developing countries. BMJ 319: 438-441.
8. Singer PA, Taylor AD, Daar AS, Upshur REG, Singh JA, Lavery JV, 2007. Grand challenges in global health: the ethical, social and cultural Program. PLoS Med 4: e265.
9. Dickens BM, 2001. The Challenge of Equivalent Protection. Ethi cal and Policy Issues in International Research 2001. Washington, DC: NBAC.
10. Sreenivasan G, 2003. Does informed consent to research require comprehension? Lancet 362: 2016-2018.
11. Sugarman J, McCrory DC, Powell D, Krasny A, Adams B, Ball E, Cassell C, 1999. Empirical research on informed consent. An annotated bibliography. Hastings Cent Rep 29: S1-S42.
12. National Bioethics Advisory Committee, 2001. Ethical and Policy Issues in International Research. Washington, DC: NBAC.
13. Weijer C, Emanuel EJ, 2000. Ethics. Protecting communities in biomedical research. Science 289: 1142-1144.
14. Senituli L, Boyes M, 2007. Whose DNA? Tonga and Iceland, biotech, ownership and consent. Lavery JV, Wahl ER, Grady C, Emanuel EJ, eds. Ethical Issues in International Biomedical Research: A Casebook. New York: Oxford University Press, 53-63.
15. Brunger F, Weijer C, 2007. Politics, risk, and community in the ICBG-Chiapas case. Lavery JV, Wahl ER, Grady C, Emanuel EJ, eds. Ethical Issues in International Biomedical Research: A Casebook. New York: Oxford University Press, 35-42.
16. Tindana PO, Singh JA, Tracy CS, Upshur REG, Daar AS, Singer PA, Frohlich J, Lavery JV, 2007. Grand challenges in global health: Community engagement in research in developing countries. PLOS Med 4: e273.
17. Emanuel EJ, Wendler D, Killen J, Grady C, 2004. What makes clinical research in developing countries ethical? The benchmarks of ethical research. J Infect Dis 189: 930-937.
18. Hodgson J, 2002. Maize uncertainties create political fallout. Nat Biotechnol 20: 106-107.
19. Rowe G, 2005. A typology of public engagement mechanisms. Science, Technology & Human Values 30: 251-290.
20. Benedict M, D'Abbs P, Dobson S, Gottlieb M, Harrington LC, Higgs S, James AA, James S, Knols BGJ, Lavery JV, O'Neill S, Scott TW, Takken W, Toure Y, 2008. Guidance for contained field trials of vector mosquitoes engineered to contain a gene drive. Vector Borne Zoonotic Dis 8: 127-166.
21. Macer DRJ, 2006. Ethics and community engagement for GM insect vector release. Boëte C, ed. Genetically Modified Mosquitoes for Malaria Control. Austin, TXs: Landes Bioscience, 148-161.
22. Enhancing Regulatory Communication. Microbial biopesticides and transgenic insects. University of California, Riverside. Available at: http://biopesticide.ucr.edu/daegu/assets/DRAFT_Daegu_Protocol_12-11-06.pdf. Accessed July 9, 2008.
23. Call for Applications. Programme grant to develop regional centres in Asia and Latin America for training in biosafety assessment for human health and the environment of the use of genetically modified disease vectors. UNICEF-UNDP-World Bank-WHO Special Programme for Research and Training in Tropical Diseases. Available at: http://www.who.int/tdr/grants/grants/ b15_asia_latinamerica.htm. Accessed July 9, 2008.